Article · 16 Feb 2026
Conference abstract
Use of guar gum nanoparticle as a therapeutic agent in peritonitis
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The main aim of drug discovery is to design drugs which can target specific cells and simultaneously exert its therapeutic effect. The use of polymer based nanoparticles is useful because their functional components either helps direct the drugs to specific cells, or act as drugs themselves from within the cells. In this study, we have used a nanoparticle designed from guar gum, a gum obtained from the seeds of the leguminous plant, Cyamopsis tetragonoloba. It is a galactomannan, with mannose and galactose present in a 2:1 ratio. The Guar gum Nanoparticle (GN), of size 80 nm, was designed by the acid hydrolysis of the guar gum, and was made mannose- rich. The aim of this study was to determine the therapeutic effect of GN in vitro and in vivo in inflammatory disease. The in vitro studies performed with RAW 264.7 macrophage cells showed successful uptake of GN in a short duration of time, via their mannose receptors, as confirmed by using mannose as a competitive inhibitor. The in vitro anti-inflammatory activity of GN on RAW 264.7 cells was confirmed by Nitric Oxide (NO) and cell proliferation (MTT) assays. Since the in vitro studies showed an involvement of macrophages, we used GN in a mouse model of thioglycollate- induced peritonitis. Several assays, including flow cytometry showed a significant decrease in the inflammation with administration of GN. Thus, we concluded that GN can be successfully used as an anti- inflammatory agent for peritonitis.
Keywords
Subjects
NanotechnologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Nanomedicine & Nanotechnology.
Article · 21 Oct 2025
Green Synthesis of Chromium(III) Oxide Nanoparticles and their Evaluation against Skin Infections
Article · 19 Jun 2025
Potential of Bhasma as Nanomedicine for Disease Management: A Synopsis
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Nanomedicine & Nanotechnology
- SubjectNanotechnology
- BylineArticles whose byline prints “Shinjini Mitra”
- BylineArticles whose byline prints “Nandita Ghosh”
- BylineArticles whose byline prints “Ena Ray Banerjee”
